FY 2025 Phase II Release 1

Background
The U.S. Department of Energy (DOE), through its Office of Science (SC), is issuing a Notice of Funding Opportunity (NOFO) for the FY 2025 Phase II Release 1 under the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. This NOFO invites eligible Phase I and Phase II awardees to apply for Phase II awards, which aim to support research and development (R&D) efforts that align with DOE objectives and facilitate the transition of innovations towards commercialization.

Grant Details
The grant encompasses several types of Phase II awards: Initial, Second (Phase IIA and IIB), and Third (Phase IIC). The Initial Phase II award is intended for R&D that meets DOE objectives from the Phase I NOFO, potentially resulting in a prototype or product.

The Second Phase II awards allow for additional financial support for new R&D tasks aligned with the original scope or extending beyond it. Eligible applicants must have completed their Phase I period of performance prior to the start date listed in this NOFO.

The expected total available funding is $87,000,000, with an anticipated 75 awards ranging from $1,100,000 to $1,600,000 each. The project period for these awards is between 12 to 24 months.

Eligibility Requirements
Eligible applicants must be domestic small business concerns (SBCs) that meet specific size standards set by the SBA. Applicants must have an active System for Award Management (SAM) registration at the award start date. Letters of Intent are required for all potential applicants.

Only currently active DOE SBIR or STTR Phase I awardees or non-DOE SBIR or STTR Phase I awardees who meet certain criteria are eligible to apply for Initial Phase II awards. Additional eligibility requirements apply for second and third phase awards.

Period of Performance
The expected project period ranges from 12 months to 24 months.

Grant Value
The total value of the grant opportunity is $87,000,000 with individual grants valued between $1,100,000 and $1,600,000.

Place of Performance
All funded research or R&D must be performed in the U.S., except under exceptional circumstances.